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Abstract.  The CD44 adhesion molecule is expressed 
by astrocytes, glial-type cells which exhibit features of 
accessory cells for immune responses in the central 
nervous system. In primary cultures of mouse astro- 
cytes, we have observed that surface expression and 
mRNA levels of CD44 are induced following stimula- 
tion with either PMA, or tumor necrosis factor alpha 
plus gamma interferon.  Comparison of CD44 splice 
variants expressed by astrocytes and a T  cell hybrid- 
oma shows that upon activation,  both cell types ex- 
press a  similar pattern of CD44 transcripts.  Thus,  in 
both cell types, CD44 transcripts  are produced which 
contain additional exons, including the exon v6 
(known to be expressed by in vivo activated lympho- 
cytes and by metastatic variants of tumor cells) as well 
as variants of larger size. In the autoimmune disease 
multiple sclerosis, activated T  cells cross the 
blood-brain barrier and lead to inflammation in the 
central nervous system. Analysis of mice with ex- 
perimental allergic encephalomyelitis,  frequently used 
as an animal model of multiple sclerosis, shows that 
CD44 is induced in vivo on glial cells surrounding 
inflammatory lesions.  Using an in vitro model for 
adhesion between T  cells and astrocytes, we have 
found a correlation between the activation state of 
these cells and their adhesion potential.  Dose- 
dependent inhibition of adhesion by hyaluronate and 
by anti-CD44 monoclonal antibody KM81  shows that 
CD44 is involved in the adhesive interactions between 
T  cells and astrocytes. 
T 
HE CD44 (Pgp-1) molecule is one of the surface anti- 
gens expressed by cells of the immune and the central 
nervous system (CNS)  1 (Quackenbush et al.,  1985; 
Flanagan et al., 1989), as well as in a variety of other tissues. 
CD44 has been extensively  studied in the lymphoid com- 
partment, as (a) a molecule involved in the development and 
differentiation  of T and B cells (Trowbridge  et al.,  1982; 
Lesley et al.,  1985;  Hyman et al.,  1986;  Miyake et al., 
1990a);  (b) an activation marker,  increased on the cell sur- 
face following  stimulation  by antigen  or mitogen (Budd et 
al., 1987; Tabi et al., 1988; Mobley and Dailey, 1992); and 
(c) an adhesion molecule involved in the interactions  of lym- 
phocytes with cells lining the so-called high endothelial ven- 
ules (HEV), an important site of cell extravasation from the 
blood into the tissues (Berg et al., 1989), and in cell binding 
to  extracellular  man'ix  (ECM)  molecules  (collagen  and 
1. Abbre~ations used in this paper: alpha-TNF, tumor necrosis factor alpha; 
CHX, cycloheximide; CNS, central nervous system; EAE, experimental al- 
lergic encephalomyelitis; ECM, extracellular matrix; FCM, flow cytome- 
try; gamma-IFN,  gamma interferon; GFAP, glial fibrillary acidic protein; 
HA,  hyahronic  acid;  HEV,  high  endothelial  venules;  MHC,  major 
histocompatibility  complex. 
fibronectin)  (Carter and Wayner, 1988; Jalkanen  and Jalka- 
nen,  1992). More recently,  CD44 was found to function as 
a receptor for hyaluronate  (HA), a major component of the 
ECM (Lesley et al.,  1990; Miyake et al.,  1990b; Aruffo et 
al.,  1990). 
The identification of a CIM4 variant (p-meta-1) capable of 
inducing a metastasizing  phenotype when transfected  into a 
rat carcinoma cell line (Giinthert  et al.,  1991), as well as a 
number  of splice variants  within  the  extracellular  mem- 
brane-proximal domain (Hofmann et al.,  1991; Jackson et 
al.,  1992;  Screaton et al.,  1992;  T61g et al.,  1993),  has 
brought more complexity to our understanding  of the CIM4 
molecule. Recently, it has been shown that lymphocyte acti- 
vation  induces a  CIM4 transcript  containing  the v6 exon 
found as part of the p-meta-1  variant  (Arch et al.,  1992). 
In the CNS, the expression of CIM4 has been found to be 
restricted to astrocytes in the white matter (Quackenbush et 
al., 1985; Girgrah et al., 1991), and a number of high-grade 
astrocyte-type  gliomas  strongly  express  surface  CIM4 
CKuppner et al., 1992). Astrocytes show some features typi- 
cal of accessory cells of the immune system. Firstly, they can 
be induced to express class II major histocompatibility com- 
plex (MHC) molecules by gamma interferon (-y-IFN) or vi- 
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et al., 1985;  Massa et al., 1987), and tumor necrosis factor 
alpha (ot-TNF) together with 3,-IFN hyperinduces class II ex- 
pression  (Vidovic  et  al.,  1990).  Secondly,  astrocytes  are 
capable of presenting antigen to T cells in a MHC-restricted 
manner (Fierz et al., 1985). Finally,  activated astrocytes can 
produce oL-TNF, as well as a number of other cytokines (Lie- 
berman et al., 1989). There are other interrelationships be- 
tween astrocytes and the immune system. Thus, in multiple 
sclerosis, a,-TNF is found in demyelinating plaques (Hofman 
et al., 1989), where astrocyte proliferation occurs (Traugott 
et al., 1985). Intracerebral accumulation of lymphocytes has 
been  shown  in  experimental  allergic  encephalomyelitis 
(EAE)  lesions  (Sriram et al.,  1982).  Astrocytes  normally 
participate  in maintaining the integrity of the blood-brain 
barrier, because they interact closely, by end-foot processes, 
with endothelial cells, which they can induce to form tight 
junctions (Hertz et al.,  1990).  Interactions between astro- 
cytes and lymphocytes are of importance in the context of 
multiple sclerosis, where such interactions may occur during 
the entry of activated  lymphocytes into the CNS, and in the 
sites of lesions. 
The aim of this study was to examine expression of CD44 
isoforms in astrocytes, and to see whether CD44 molecules 
are involved in the interactions between astrocytes and lym- 
phocytes.  In primary cultures of astrocytes from the new- 
born mouse brain, we show that transcript levels and surface 
expression of total CIM4 is up-regulated following activa- 
tion with either the tumor-promoting agent PMA, or ot-TNF 
plus ~/-IFN.  In the spinal cord of mice with EAE-induced 
pathology, we find that CIM4 expression is strongly induced 
on glial cells surrounding  inflammatory plaques.  In addi- 
tion, we show that a number of CD44 splice variants, includ- 
ing types containing exon v6 and of size comparable to the 
p-meta-1  variant,  are induced in astrocytes upon activation. 
Rat astrocytes in culture express on the cell surface low levels 
of v6-containing CD44 molecule(s), recognized by the anti 
p-meta-1 mAB 1.1ASML,  and v6 expression is increased fol- 
lowing in vitro stimulation. Interestingly,  T cells and astro- 
cytes show a very similar pattern of CD44 expression and 
induction. Finally, we show by an in vitro adhesion assay that 
a  T  cell  hybridoma  line  can  adhere  to  an  astrocyte 
monolayer.  This interaction is HA-dependent, and can be in- 
hibited by mAb KM81  directed to the HA-binding  site of 
CD44.  Our results therefore demonstrate that CD44 is in- 
volved in direct contacts between T cells and astrocytes. 
Materials and Methods 
Cell Cultures 
Astrocyte cultures were established from newborn mouse brains, following 
a method described in the rat by Booher et al. (1972).  Brain hemispheres 
from day 0 or 1 (C57BI/6 ×  SJL) Fi mice (bred in the LGME Facility; 
Strasbourg,  France) were isolated, meninges removed, and a single cell sus- 
pension prepared by repeated passages through a 21G hypodermic needle. 
Total  cells were plated on poly-L-lysine  (Sigma Immunoehemicals, St. 
Louis,  MO)  coated  100  ×  20-ram  plastic  dishes  (Falcon,  Bectun- 
Dickinson, NJ) or chamber slides (Polylabo,  Strasbourg,  France) in Way- 
mouth medium (Gibco,  Life Technologies  Ltd.,  Paisley,  Scotland)  sup- 
plemented with 10% FCS,  at a density corresponding to one brain to 18 
ml medium (,~106 cells/ml), and incubated at 37°C  in a  5%  CO2 hu- 
midified atmosphere.  In these culture conditions, even after 3-4 d, astro- 
cytes were the predominant cell type. Thus, >95 % of cells stained with an 
antibody to glial fibrillary acidic protein (GFAP).  Very few macropbages 
were present, as assessed by staining for MAC-I, and microscopic examina- 
tion showed that few (<1%) fibroblasts  were present. 
The HILl  T cell hybridoma, generated by fusing the AKR thymoma 
BW5147 with fetal mouse thymocytes grown in IL-2 as described (Ceredig 
et al., 1989), was grown in supplemented DME (Cerottini et al., 1974) con- 
taining 10% FCS. Cells were stimulated using the tumor-promoting agent 
PMA (Sigma Immunocbemicals) at a concentration of 50 ng/ml for astro- 
cyte cultures,  and 10 ng/ml for the Hl1.1  cell line. Recombinant human 
c~-TNF and mouse 7-IFN (gifts from Dr. C. Benoist, LGME) were added 
at concentrations of 10 ng/ml and 200 IU/ml, respectively. The protein syn- 
thesis inhibitor cyclobeximide  (CHX) was used at 10 ng/ml. 
Immunostaining and FCM  Analysis 
Astrocyte  cultures grown on poly-L-lysine-coated  chamber slides  were 
stained for CD44 surface  expression using the rat anti-mouse mAb IM7 
(a gift of Dr. R. Hyman), followed by FITC-conjugated  sheep anti-rat Ig 
(Silenus,  Melbourne, Australia).  The anti-GFAP  antibody was rabbit Ig 
(Dako, Biosis, France). Cells were stained for GFAP after permeabilization 
in 0.3 % saponin, followed by Texas red-conjugated goat anti-rabbit F(ab')2 
(Jackson ImmunoResearch Labs, Inc., West Grove, PA). Cells were fixed 
with 1% paraformaldehyde  in PBS, and photographs were taken under a 
fluorescence  microscope (Zeiss, Strasbourg,  France). 
Spinal cords and brains from normal and EAE mice were provided by 
Dr. H. Bedmer, 10-#m frozen sections were fixed with 1% paraformalde- 
hyde and stained for CD44  expression.  Non-specific  fixation  of biotin- 
labeled fiVI7 was prevented by first incubating sections in I% BSA. Fixed 
antibody was  revealed  by avidin-phosphatase (Vectastain  ABC; Vector 
Laboratories, Burlingame,  CA), after blocking of endogenous phospbatase 
activity with 50 ~  levan6sole (Sigma Immunochemicals). Sections were 
lightly counterstained with hematoxylin. 
Fo  r flow cytometry (FCM) analysis, astrocytes were trypsinizad (3 rain, 
0.04%  trypsin in PBS) from dishes, dissociated,  and washed in medium, 
and ,,05 x  105 cells were stained by indirect immunofluorescence.  Single 
staining for CD44 and GFAP was done using the reagents described above 
for  Fig.  2,  and  with biotin-iabelad IM7  followed  by Av  Frrc  (Bectun- 
Dickinson & Co., Mountain View, CA) for Fig.  1. The mouse antibody 
I.IASML directed to the v6-encoded region of CD44 was described by 
Matzku et al. (1986). Rat astrocytes were double stained with biotin-labeled 
I.IASML and Av  Frrc, and with anti-GFAP antibody as described above. 
Staining for the MAC-I Ag was with the rat anti-mouse MAC-I mAb IvlI-70 
(a gift from Dr. I. F. C. McKenzie), followed by FITC-conjugeted  sheep 
anti-rat IgG. FCM analysis was carried out on an ODAM ATC 3,000 flow 
cytometer 0Nissembourg,  France). 
RNA Preparation and Northern Blot Analysis 
RNA was purified by centrifugation on a 5.7 M cesium chloride cushion as 
described (Maniatis et ai., 1982), and separated according to size on a 1% 
agarose formaldehyde gel which was blotted onto a Hybund-N nylon filter 
(Amersbam, Les Ulis, France). Probes for hybridiTation were obtained by 
random priming of the CD44 (Fgp-1) cDNA 1.3-kb EcoRI fragment from 
plnsmid MHR6-Prk5  (Zhou et al.,  1989), the variant CD44 region exons 
v4 to  vl0 cDNA,  and the O-actin  cDNA  (gift from Dr.  A.  Hanauer, 
LGME). Bands on X-OMAT  Kodak films (Rochester,  NY) exlxrea~d for 
varying lengths of time were scanned using a Biocom Compaq gel scanner, 
and the band intensities analyzed using the program ELPHOR (Biocom, 
Les Ulis, France). 
PCR Amplification of CIM4 Variant  Region 
Oligonucleotides  were used hybridizing to CD44 constant region 5' and Y 
of the variant region, and in exons v6 and v7 of the variant region (see Fig. 
7 a). Aliquots of totai RNA samples (,,ol #g) were reverse transcribed using 
20 ttg/ml oligoT primer in 50 mM Tris HCI, 20 mM KCI, 10 mM M8C12  , 
5 mM DTT, and 1 mM of each dNTP.  AMV reverse transcriptnse (9 U) 
and ribonuclense inhibitor (6 U) (Amersham) were add,y] in 20/d final vol- 
ume, and incubation was for 40 min at 42°C.  The reaction was stopped by 
adding 80 #1 H20, and 1/d of this cDNA preparation was submitted to 
PCR amplification.  The PCR amplification was carried out in a buffer con- 
taining 10 mM Tris HC1, 50 mM KCI, 2 mM MgCI2, 1% gelatin and 200 
#M of each dNTP,  1 #M of each primer pair and 0.5 U of Taq polymerase 
(Perkin Elmer Cetus, Norwalk,  CT) ~__,~_~  in a final volume of 20/d. Sam- 
pies were  denatured 10 min at 92°C, followed by 35 cycles of 30" at 92°C, 
20" at 60°C,  and 1 min at 72°C, with a 2" extension at each cycle, and 
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agarose gel,  blotted onto Hybond-N  + (Amersham), and hybridized to 
CD44 variant region eDNA probes corresponding to exons v6-7 and vl0 
obtained by random-priming. Filters were exposed to Kodak X-Omat films 
for intervals of several hours to 2 d. 
Adhesion Assays 
Astrocyte~  were trypsinized from primary cultures, seeded in fiat-bottomed 
96-wells plates (Falcon, Becton-Dickinson, NJ), and allowed to grow for 
3 d, to obtain a confluent ceil layer. The adhesion protocol was a modifica- 
tion of that de-~'ibed  by Lepesant et al. (1990). Plates were kept on ice to 
minimize metabolic activity of the  ceils.  Medium was  aspirated and 
replaced by graded numbers of 5tCr (Amersham)-labeled  HI1.1 T ceils in 
100/tl cold culture medium. Cells were allowed to settle for 1 h, and then 
wells were filled with sufficient  cold PBS to obtain a positive meniscus, and 
carefully sealed with parafilm, avoiding the formation of air bubbles. The 
plates were then inverted and centrifuged for 5 rain at 500 rpm, and flicked 
to eliminate all medium and unbound cells. The remaining  bound cells were 
lysed in 10% NP-40, and the radioactivity was counted. The percentage of 
adhesion was calculated as a ratio betweea the clam  from bound cells (tripli- 
cate or quadruplicate samples) and the total input clam. Negative controls 
included H1L1 ceils treated with 0.2% trypsin for 30 rain at 37°C, and also 
Hll.1 ceils added to empty plastic wells. When needed, PMA was added 
to astrocytes or HILl ceils ,x,15 h before the assay. Hyaluronidase  treatment 
was for 1 h at 37°C, in medium containing 1 ~,g/ml  hyaluronidase  (provided 
by M. Gilbert, LGME). HA (see Fig. 8 c for concentrations) (Sigma Im- 
munochemicals) was added in the wells together with the Hll.I cells just 
before the assay, mAb inhibition assays were performed in the presence of 
culture supernatants of anti-CD44 mAbs KM81 or KM201 (kind gifts of 
Dr. E Kincade), or IM7. Preincubatiun of either the astrocyte monolayer, 
or the Hll.1 T cells in the presence of culture supernatants of monoclonal 
antibodies KMSI or IM7 was for 1 h on ice. The remaining free antibodies 
were washed away with culture medium before the addition of T cells into 
the microwells. 
Results 
CD44 Is Expressed by Primary Cultures of 
Mouse Astrocytes 
Differentiated astrocyte populations expressing GFAP were 
obtained within 2-3 d of culture in 10%  serum (Lillien and 
Raft,  1990).  Fig. 1 (left) shows a typical display of forward 
versus side scatter signals from in vitro cultured astrocytes. 
Based on the cytogram display, cells could be subdivided 
into three subpopulations of small (No. 1), medium (No. 2), 
and  large  (No.  3)  cells.  Such  subpopulations  could  cor- 
respond to those defined by morphological criteria, namely 
fibrous- and protoplasmic-type astrocytes. Larger cell popu- 
lations stained more brightly for GFAP, as mean  fluores- 
cence intensities of populations No. 1, No. 2, and No. 3 were 
102,  139,  and  205,  respectively (middle).  Expression  of 
CD44 increased with increasing cell size, thus 59% of popu- 
lation No.  1, 75% of No. 2, and 92% of No. 3 were CD44+ 
(right).  During  development  in  culture,  FCM  analysis 
showed that CEM4 expression appeared simultaneously with 
GFAP (not shown). 
Induction of CD44 Expression by Astrocytes 
CD44 expression on the surface of T  lymphocytes has been 
shown  to  increase  following  stimulation with  antigen,  or 
PMA and calcium ionophore (Budd et al., 1987; Tabi et al., 
1988;  Mobley and Dailey, 1992).  PMA treatment of astro- 
cytes activates protein kinase C and induces cell proliferation 
(Murphy et al.,  1987).  To see whether activated astrocytes 
show an increase in CD44 expression, primary cultures were 
treated with PMA and analyzed for surface CD44 expres- 
sion. As shown in Fig. 2,  CD44 was weakly expressed by 
total unstimulated astrocytes. It should be noted that indirect 
staining with IM7 SN (as shown in Fig. 2) was always weaker 
than by the biotin-avidin method. At 4 h after PMA stimula- 
tion, the staining intensity had increased and 69 %  of cells 
were positively stained.  The increase in CD44  expression 
was seen in three independent experiments. 
To look at the distribution of CD44 on cultured astrocytes, 
fluorescence microscopy was carried out. By this technique, 
CD44 was found to be unequally distributed on the surface 
of  the  cells,  being  more  highly  expressed  on  astrocyte 
processes  and  at  sites  of contact  between  adjacent  cells 
(Fig. 3). 
It is known that 7-IFN together with a-TNF superinduces 
MHC  class  II  expression  on  astrocytes  (Vidovic  et  al., 
1990). In addition, a,-TNF can be produced by activated as- 
trocytcs, and is detected in multiple sclerosis lesions (Lie- 
berman et al., 1989; Hofman et al., 1989). To see what effect 
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Figure 1. Phenotyp¢ of astro- 
cytcs in primary cultures from 
newborn  mouse  brain  cells. 
Cells  from  a  2-wk-old  pri- 
mary culture were stained in 
suspension for the astrocyfic 
marker GFAP and for CIM4, 
and analyzed by FACS.  Due 
to  heterogeneity in  size and 
granulation, t~aresem~ by for- 
ward  and  side  scatter,  the 
bulk was  divided into  three 
populations by gating; shown 
are  the  fluorescence  histo- 
grams for GFAP (mean fluo- 
rescence intensities are indi- 
cated) and the percentage of 
CD44  +  cells  (staining  with 
the biotinylated IM7 mAb) in 
each subpopulation. 
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Figure 2. PMA stimulation of astroeytes primary cultures induces 
CIM4 surface expression. After 4 h of PMA treatment, cells from 
1-m-old  primary cultures were stained in suspension using the IM7 
mAb in culture supernatant, and analyzed by FACS for CD44 sur- 
face expression. The percentage of positive cells is indicated. 
these  cytokines  had  on  CD44  expression by  astrocytes, 
r-Hu-o~-TNF, Mu-~-IFN, or both factors were added to as- 
trocyte  primary cultures. As shown in Fig. 3 b, this treatment 
resulted in the induction of CD44 surface expression, which 
was again more brightly expressed along astrocyte processes 
and sites of intercellular contact. 
To see whether CD44 is induced on astrocytes in vivo, sec- 
tions of spinal cord from either normal (Fig. 4, a  and c) or 
mice with EAE-induced pathology (Fig. 4, b  and d) were 
subjected to immunophosphatase staining. As shown in Fig. 
4, b and d, CD44 was strongly expressed by glial cells sur- 
rounding inflammatory lesions. The level of CD44 expres- 
sion on these glial ceils was clearly above that found in the 
white matter of normal mice (Fig. 4, a  and c). 
Northern Blot Analysis of CD44 Transcripts in 
Activated Astrocytes 
We were interested to see whether in astrocytes, as in T cells 
(Haegel and Ceredig, 1991), cell activation resulted in an in- 
crease in  CD44  transcripts.  Therefore, Northern analysis 
was carded out of total RNA from unstimulated and PMA- 
stimulated primary astrocyte cultures. In T cells, we have al- 
ready shown that the predominant CD44 transcripts are of 
4.5, 3.5, and 1.6 kb with the 4.5-kb transcript being the domi- 
nant form. In contrast, in fresh unstimulated astrocytes, the 
only clearly distinguishable CD44 transcript was of 4.5 kb 
(Fig. 5 a); transcripts of  lower sizes were present but less dis- 
tinguishable than in T cells. Activation by PMA resulted in 
a marked increase of CD44 transcripts. In this experiment 
(Fig. 5), the astrocytes used had been in culture for 14 d be- 
fore PMA stimulation. The ratio of CD44/actin transcripts, 
as determined by scanning autoradiograms, was 6.2-fold af- 
ter 4-h stimulation and  18.5-fold after 18 h.  In agreement 
with our previous results with T cells (Haegel and Ceredig, 
1991), this increase in CD44 transcripts was prevented  by the 
Figure 3.  ClM4  surface expression  in  adherent  astroeytes pri- 
mary cultures, either tmstimulated (a), or stimulated overnight with 
r-Hu-tx-TNF  +  Mu-3,-IFN  (b).  Fluorescence  immtmostaining 
using biotin-labeled IM7 mAb. 
addition of the protein synthesis inhibitor CHX. Thus com- 
pared with control cultures, in the presence of CHX, CD44 
transcripts levels had increased only 2.5-fold after 4 h and 
2.6-fold after 18 h, respectively. This result suggests that de 
novo protein synthesis was required for the increase of CD44 
transcription after stimulation. 
In  addition  to  hybridization  with  an  actin  probe  (not 
shown), the same filters were hybridized with a Thy-1 probe. 
Thy-1 is a cell surface antigen expressed by mouse and hu- 
man astrocytes. As shown in Fig. 5 b, stimulation with PMA 
in the presence or absence of CHX did not significantly alter 
Thy-1 transcript levels. 
In the experiment shown in Fig. 5, the astrocytes used were 
from 2-wk-old cultures. At this time it is known that astro- 
cytes are optimally responsive to PMA (Honegger et al., 
1986). Later experiments used astrocytes from 3-4-wk-old 
cultures and the increase in CD44 transcripts was relatively 
more modest. Thus astrocytes were stimulated with either 
PMA or ~-IFN and ot-TNF alone or in combination. With 
,y-IFN or ot-TNF alone, the increase in CD44 transcripts, 
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induced in EAE lesions. Im- 
munophosphatase staining for 
CD44  in  frozen  sections  of 
normal  (a  and  c)  and  EAE 
mouse (b and d) spinal cord, 
counterstained with hematox- 
ylin. In inflammatory lesions, 
where mononucleated  ceils lo- 
calize,  CD44  is  strongly ex- 
pressed  by  the  surrounding 
glial cells. 
Figure 5. Northern Blot analysis of  CD44 and Thy-1  transcripts fol- 
lowing PMA stimulation of astrocytes primary cultures. Ceils in 
2-wk-old primary cultures were stimulated with PMA in the pres- 
compared to actin control, was  1.3-  and 2.2-fold, respec- 
tively. The combination of  7-IFN and a-TNF had  an  additive 
effect on CD44 transcripts levels, resulting in a 2.7-fold in- 
duction. Fig. 6 shows the results from a minimum of three 
experiments, in which the CD44/actin ratio was determined 
in astrocytes stimulated overnight with the indicated agents. 
Thus  PMA  consistently increased  CD44  transcripts,  and 
o~-TNF plus -y-IFN always resulted in an additive effect. 
Variant CD44 Molecules in Act/vated Astrocytes 
Because of  the increasing variety of  known CD44 splice vari- 
ants (Giinthert et al.,  1991; Hofmann et al.,  1991; Jackson 
et al., 1992; Arch et al.,  1992; Screaton et al.,  1992; Ttlg 
et al., 1993), we decided to determine which CD44 variants 
were being expressed by unstimulated and stimulated astro- 
cytes. Importantly, we asked whether astrocytes and T cells 
may be expressing the same variant forms of  CD44. Initially, 
Northern blots of total RNA were performed using a probe 
for the v4 to vl0 exons. The signals obtained were too weak 
ence or absence of the protein synthesis inhibitor CHX or calcium 
ionophore, and total RNA was isolated at the times indicated. The 
filter was hybridized using cDNA probes for CD44 (a) and Thy-1 
(b). Hybridization using a/~-actin probe (not shown) indicated that 
equal amounts of RNA were loaded. 
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Figure 6. Induction of CD44 transcripts in stimulated astrocyte pri- 
mary cultures. Northern  Blots from 3-wk-old astrocTte primary 
cultures stimulated overnight with PMA or Mu-3,-IFN, r-Hu-~- 
TNF, and both factors, were scanned and the intensities of CD44 
bands were compared to those of 3-actin.  Results shown are the 
mean of three experiments. 
for the  interpretation of results,  although  %tandard-type" 
CD44 could be easily detected on the same filters, suggest- 
ing that mRNAs encoding splice variants of CD44 are pres- 
ent in lower amount than standard CD44 form within the 
cells. Therefore, we undertook a PCR strategy. As shown in 
Fig. 7 a, combinations of four oligonucleotides (A-D) were 
used in these PCR experiments. Thus oligos A and D (Fig. 
7 b, lanes 3 and 6) amplified from the 5' constant through 
to the 3' constant region of CD44 and should theoretically 
amplify all variable domain, Oligos B and D (Fig. 7 b, lanes 
1 and 4) would amplify from v6 to the 3' constant region, 
whereas A and C (in Fig. 7 b, lanes 2 and 5) amplify from 
the 5' constant region up to and including v7. These PCR am- 
plified fragments were Southern blotted with probes to either 
v6-7 (Fig. 7 b, top)  or vlO (Fig.  7 b, bottom). 
As shown in Fig. 7 b  (lanes 1 and 4), two bands of 320 
and 190 bp hybridizing to probes v6-7 (Fig. 7 b, top) but not 
vl0 (Fig. 7 b, bottom) were observed in PMA-stimulated as- 
trocytes. Non-stimulated astrocytes did not usually express 
these "recta-type" CD44 variants, of sizes corresponding to 
the p-meta-1 (Gfinthert et al., 1991) and to the v6-containing 
isoform shown to be expressed by in vivo activated lympho- 
cytes (Arch et al.,  1992). In contrast, the Hll.1 T cell line, 
either unstimulated  or  stimulated,  consistently expressed 
these CD44 variant forms. The band of "o800 bp (Fig. 7 b, 
lanes 4, top and bottom) containing v6 (top), vl0 (bottom) 
plus additional exons is induced in both astroeytes and Hll.1 
cells. Lanes 2  and 5  (top) show that variants containing v7 
were more abundant in stimulated vs.  unstimulated astro- 
cytes, but remained the same in Hll.1 ceils. A band around 
500 bp,  a  size corresponding to  the p-meta-1  variant,  is 
clearly induced in activated astrocytes. A  smaller band of 
280 bp indicates the presence of a variant containing one ad- 
ditional exon 5' to the v7 exon, expressed by astroeytes and 
H11.1 cells regardless of their activation state. In lanes 3 and 
Figure 7. PCR detection of CD44 variants 
expressed in astrocyte primary  cultures 
and in the  Hll.1  T  cell line  stimulated 
with PMA. (a) PCR strategy used to dis- 
tinguish between "meta-types  ~ and larger 
CD44 variants. A schematic structure of 
the  p-meta-1 variant  (Giinthert  et  al., 
1991) is represented; "standard  ~  CD44 se- 
quence (open bars), exons from the vari- 
ant region (dark bars), and the transmem- 
brane  region  (hatched bar) are  shown. 
Localization  of the  putative  additional 
exons (hatched lines) identified in larger 
CD44 variants is according to T61g  et al., 
1993. Oligonucleotides A, B, C, and D 
hybridize  to  positions  653-680,  1039- 
1070, 1146-1173, and 1328-1356, respec- 
tively. (b) cDNA from non-stimulated or 
PMA activated astrocytes and T cell line 
HILl  were  amplified using  the primer 
pairs indicated. Amplification  using oligus 
B and D (1-4) perndts to distinguish be- 
tween  "meta-type"  variants,  producing 
bands of 320 bp (p-meta-l) and 260 bp 
(v6-containing variant) (Arch et al., 1992) 
hybridizing  to the v6-7 probe but not to the 
vl0 probe,  and other variants producing 
larger bands hybridizing to both probes. 
Amplification using oligos A and C (2-5) 
identifies variants containin~ exon v'/. Use 
of the two external oligos A and D (3-6) 
permits amplification of the whole CD44 
variant region. 
The Journal of Cell Biology,  Volume 122, 1993  1072 6, only one main band of around 400 bp was detected. We 
failed  to  amplify  larger  variant  forms  with  these  oligos. 
Nevertheless, lanes 3 and 6 (top) show that a variant contain- 
ing exons v6 and/or vT, and of size corresponding to the v6- 
containing variant (Arch et al., 1992), is induced upon astro- 
cyte  activation.  This  form  is  constitutively  expressed  by 
Hll.1 cells. In addition, a vl0-contalning variant, weakly ex- 
pressed  by astrocytes,  is  induced  upon  PMA  stimulation 
(bottom). Although not quantitative, the PCR results shown 
in Fig.  7 b  were routinely obtained.  As mentioned above, 
some non-stimulated astrocytes expressed weakly v6-7-con- 
taining transcripts. 
To detect variant forms of CD44 on the cell surface of as- 
trocytes, specific antibodies are required which are not yet 
available  for  the  mouse  molecules.  The  mAb  1.1ASML 
(Matzkn et al.,  1989) recognizes a region encoded by the 
variant region exon v6, present in the p-recta-1  variant of 
CD44. The 1.1ASML epitope is induced in activated rat lym- 
phocytes following antigenic stimulation in vivo (Arch et al., 
1992). Therefore, to demonstrate the surface expression of 
v6-contalning CIM4 molecules, rat astrocytes were stained 
by two color immunofluorescence for GFAP and 1.1ASML. 
Fig. 8 a  shows the GFAP staining profile, and Fig.  8 b the 
1.1ASML profile of GFAP-positive cells. Unstimulated astro- 
cytes stained very weakly with 1.1ASML, but the presence 
of v6-contalning CD44 was clearly detectable on the surface 
of PMA-activated astrocytes. These results demonstrate the 
expression of v6-contalning CIM4 variant on the surface of 
stimulated rat astrocytes. 
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Figure 8. Induction of v6-containing CD44 on the surface of stimu- 
lated rat astrocytes. Rat astrocytes in 2-wk-old primary  cultures 
were stained in two colors for the astrocyfic marker GFAP (a) and 
for the v6-encoded region of CD44 recognized by mAb 1.1ASML. 
The 1.1ASML staining profile of the GFAP-positive cells is shown 
in (b), before (dotted) and after (bold) 24 h of in vitro stimulation 
with 50 ng/ml PMA. 
In conclusion, astrocytes can express several variant forms 
of CD44, including "meta-type" variants, and the latter are 
increased in PMA-stimulated cells. The 800-bp PCR frag- 
ment (Fig. 7 b, lanes 4) containing exons v6 to vl0 was also 
found to be induced in astrocytes by (x-TNF and -y-IFN (not 
shown). In general, there is a striking similarity between the 
profile of CD44 variants expressed by activated astrocytes 
and activated T cells. 
Involvement of CD44 in Adhesion between Astrocytes 
and a T Cell Line 
In the context of inflammatory diseases of the CNS, most 
notably EAE, the direct interaction between activated T cells 
and astrocytes may play an important role in the localization 
of T cells to sites of brain injury. ~TNF expression and as- 
trocyte proliferation have been detected in areas surrounding 
the demyelinating plaques in the CNS (Hofman et al., 1989; 
Traugott et al.,  1985). 
To study the interaction between T cells and astrocytes in 
more detail, an in vitro adhesion assay was developed. In this 
assay, 5'Cr-labeled Hll.1  T  hybridoma cells were allowed 
to adhere to monolayers of unstimulated or stimulated astro- 
cytes. Using this assay,  we could show that the adhesion of 
HII.1 cells to astrocytes was augmented following stimula- 
tion of either Hll.I cells or astrocytes (Fig. 9 a). Stimulation 
of both H11.1 and astrocytes resulted in increased adhesion. 
Control experiments  showed that spontaneous 5~Cr release 
by Hll.1 cells did not increase following PMA stimulation 
(not shown). To show the role of CD44 in this adhesion pro- 
cess, Hll.1 cells were allowed to adhere to PMA-stimulated 
astrocytes which had been either left without further treat- 
ment, or after treatment with hyaluronidase (Fig. 9 b). Treat- 
ment with hyaluronidase clearly inhibited the adhesion  of 
Hll.1  cells  to  PMA-activated  astrocytes.  Addition  of the 
CD44 ligand HA led to a dose-dependent decrease in cell 
adhesion  (Fig.  9  c).  Control  experiments  showed no  in- 
creased astrocyte detachment  following either PMA treat- 
ment or addition of HA.  After PMA treatment  (Fig.  9  c, 
right), adhesion was more resistant to blocking by HA, sug- 
gesting that other adhesion molecules or non-HA binding 
CD44 variants may participate in the binding. Finally, anti- 
CD44 antibodies were tested for their ability to inhibit the 
binding between astrocytes and H11.1 cells. Presence of the 
KM81 mAb inhibited in a dose-dependent fashion the adhe- 
sion of Hll.1  cells to astrocytes (Fig.  9 d,  left).  This anti- 
CD44 antibody is known to recognize the HA-binding do- 
main of CD44 and importantly stains both Hll.1 cells (Fig. 
9 d, right) as well as astrocytes (not shown). In contrast, the 
KM201  mAb  did  not  inhibit  adhesion  and  did  not  stain 
brightly neither Hll.1  cells (Fig. 9 d, right) nor astrocytes 
(not shown).  The IM7 mAb did not inhibit adhesion  (not 
shown), but did stain both astrocytes (Figs.  1 and 2) and 
Hll.1 cells (Haegel and Ceredig,  1991).  Pretreatment of ei- 
ther the astrocyte monolayer, or the Hll.1 T cells with mAbs 
KM81 or IM7 (Fig.  9 e) showed that CD44 molecules on 
both cell types participated in the adhesion. 
Discussion 
We have examined CD44 expression by astrocytes in pri- 
mary  cultures  of  newborn  mouse  brains.  In  10%  FCS 
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within 3-4 d, the differentiation process being much more 
rapid than in vivo (Lillien and Raft, 1990). The resulting cell 
population is heterogenous in  size and  CD44  expression, 
and the highest percentage of CD44  + cells is found among 
the large cell population (Fig. 1). This may reflect a different 
activation state among distinct populations, larger cells be- 
ing a more "active" population, a situation analogous to cul- 
tures of lymphocytes. A  number of astrocyte subtypes have 
been  described,  namely  fibrous-  and  protoplasmic-types, 
which differ by their morphology (Tardy, 1991).  Our results 
suggest that these subtypes show a difference in surface ex- 
pression of CD44. 
We have found that astrocytes stimulated with PMA or 
~-TNF  and  3,-IFN  increase  not  only  surface  expression 
(Figs. 2 and 3) but also CD44 transcript levels (Figs. 5 a and 
6). This phenomenon is more striking in 2 wk-old primary 
cultures than in older cultures. This difference could be be- 
cause cells in 2-wk-old cultures are more actively dividing 
and more sensitive to PMA stimulation (Honegger,  1986). 
There is an interesting similarity in the pattern of CD44 
transcripts expressed in astrocytes and in T cells (Haegel and 
Ceredig,  1991). In T cells a 4.5-kb mRNA is predominantly 
produced,  together  with  a  number  of smaller  size  tran- 
scripts.  These smaller CD44 transcripts could correspond 
either  to  varying  degrees  and  sites  of  polyadenylation 
(Schtivelman and Bishop,  1991)  and/or to different splice 
variants of the CD44 molecule. This analogy is strengthened 
by the finding that, in astrocytes as in T cells, CD44 expres- 
sion is upregulated by PMA stimulation. In both cell types, 
Figure 9.  Adherence of the T cell line Hll.1 to astrocyte monolayers. (a) Adhesive interaction  is increased  after PMA activation.  104 
HII.I cells were added per microwell containing monolayers of astrocytes from primary cultures.  Dissociation curves (Lepesant et al., 
1990) were obtained by spinning reversed plaques for 5 rain at 200, 600,  1,000, and 1,400 rpm, and the percentages of remaining bound 
Hll.1 cells were calculated. Open circles correspond to unstimulated astrocytes and T cells; astrocytes (A), HILl T cells (A), and both 
cell types (D) were PMA-stimulated  15 h before the experiment.  (b) Adhesion is inhibited by hyaluronidase treatment  of the astrocyte 
monolayer. Graded numbers of Hll.1 T cells were added on PMA-activated astrocyte monolayers, with (D) or without (i) previous hyal- 
uronidase treatment of the astrocytes, and the percentages of remaining bound Hll.1 cells were determined.  (c) Adhesion is inhibited in 
the presence of HA.  104 Hll.1 T cells were added per microwell containing astrocyte monolayers, either PMA activated (r/g/u) or un- 
stimulated (left), and incubated in the presence of HA at 100/~g/ml (grey bars), 500/~g/ml (hatched bars) or in the absence of HA (black 
bars). The percentages  of bound cells were determined  as previously. (d) Inhibition of adhesion in the presence of mAb KM81. Serial 
dilutions of KM81 (m) or KM201 (o) culture supernatants were added to the microwells in the adhesion assay (left). FCM analysis (right) 
showed that KM81 mAb brightly  stained H11.1 cells (bold profile),  whereas KM201 did not (dotted profi/e).  (e) Pretreatment  of either 
the astrocytes, or the Hl1.1 T cells with mAb KM81 inhibits adhesion.  The astrocyte monolayer, or the Hl1.1 cells, were preincubated 
for 1 h  on ice  in the  presence  of mAb supernatants  KM81 or IM7. Cells  were  washed before addition  of 105 Hl1.1 cells  into  the 
microwells. The percentages of  maximal binding which was obtained in the absence ofmAb pretreatment were calculated from two indepen- 
dent experiments. 
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protein synthesis dependent.  However, in contrast to our 
results with T cells (Haegel and Ceredig, 1991), PMA stimu- 
lation of astrocytes did not decrease Thy-1 transcript levels 
(Fig.  5 b),  reflecting the complex regulation of the Thy-1 
gene in different mouse tissues. It is known that Thy-1 ex- 
pression in the brain, thymus, and peripheral T cells is regu- 
lated by tissue-specific enhancers present in distinct introns 
of the Thy-1 gene (Vidal et al.,  1990). 
A PCR strategy was used to determine which CD44 splice 
variants were transcribed in astrocytes and in Hll.1 T cell 
hybridoma cells, before and after in vitro cell activation. The 
splice variants expressed by both cell types upon activation 
were similar (Fig. 7 b). Interestingly, "meta-type" variants 
containing exons v6 and/or v7 but not vl0 can be expressed 
by unstimulated cells, and they appear to be induced in astro- 
eytes activated with PMA or with ot-TNF and ),-IFN. That 
v6-contalning CIM4 appears on the surface of activated as- 
troeytes was confirmed by staining rat astrocytes with the 
mAb 1.1ASML (Fig. 8 b), which is known to detect p-meta-1 
and the v6-containing variant of rat CD44. In view of the re- 
cent study (Arch et al., 1992) showing that a CD44 variant 
containing exon v6 is induced in the lymphocyte compart- 
ment following antigenic stimulation, it is likely that this 
feature can be extended to astrocytes in the neuroglial com- 
pa,ia~ent. Moreover, we found that larger CD44 variants, 
containing exons v6 and vl0, were also induced upon activa- 
tion of both astrocytes and the HI 1.1 T cell line. Attention 
must be pointed to possible contamination of astrocyte pri- 
mary cultures with different cell types.  However,  similar 
amounts of CIM4 variant forms could be amplified using 
equal quantities of RNA from activated Hll.I cells and acti- 
vated astrocytes. Therefore, possible contamination of the 
primary astrocytes cultures by macrophages, which never 
exceeded 3 %, and fibroblast (<1%), is unlikely to explain the 
results obtained in our PCR experiments. In addition, two 
color FCM (Fig. 8) directly demonstrates that upon stimula- 
tion, astrocytes defined as GFAP-positive cells express a v6- 
containing, recta-type CD44 variant. Therefore, we believe 
that our PCR experiments faithfully reflect the expression of 
CD44 variants in astrocytes. 
Our studies demonstrate that tx-TNF and 3,-IFN have an 
inducing effect on CD44 expression. As mentioned previ- 
ously these cytokines have been shown to play a major role 
in cell activation, inflammation  and immune reactions within 
the CNS. We show that they can induce an increase in CD44 
surface expression as well as transcript levels (Figs. 3 and 
6). When both ct-TNF and 7-IFN are present, the induction 
is quantitatively stronger than that observed with PMA, and 
these cytokines appear to have an additive effect on CD44 
mRNA induction, ot-TNF and 3,-IFN  have been shown to 
work on cell activation via numerous mechanisms, including 
effect on Na÷/H  ÷ transport and inhibition of lipoprotein li- 
pase (Chung et al.,  1991; Beutler et al.,  1985).  A detailed 
study of the  CD44  promoter  is  necessary to  determine 
whether particular consensus sequences are responsible for 
CIM4 induction by ot-TNF and ),-IFN, directly or indirectly. 
Interestingly, astrocytes from EAE-susceptible and -resistant 
strains show differential expression of ot-TNF (Chung et al., 
1991), and an antibody to ot-TNF has been shown to prevent 
transfer of EAE (Ruddle et al.,  1990).  OUr results suggest 
that in vivo, expression of the CD44 adhesion molecule by 
astrocytes  is  increased  in  conditions  where  ot-TNF  and 
7-IFN are present, as in inflammation, gliosis, and immune 
reactions in the CNS. 
Immunofluorescence microscopy shows that expression 
of CD44 is increased at sites of contact between cells and 
along astrocyte processes,  suggesting a  role for CD44  in 
homotypic adhesion. Immunoperoxidase staining of normal 
mouse spinal cord sections (Fig. 4, a  and c) indicated that 
CD44 was expressed in the white matter and in perivascular 
areas.  Interestingly,  we  show  that  CD44  expression  is 
strongly induced on glial ceils surrounding inflammatory le- 
sions in the white matter of EAE mouse spinal cord (Fig. 4, 
b and d). As mentioned above, astrocytes have been reported 
to interact closely with endothelial cell types in the brain 
through foot processes, and to induce the formation of tight- 
junctions (Hertz et al., 1990). Thus, a central role in the con- 
trol of exchanges between the immune system and the brain 
appears to be held by astrocytes and endothelial cells (Fon- 
tana and Fierz,  1985).  In the immune system, CD44 has 
been shown to allow adhesion of lymphocytes to high en- 
dothelial venules, leading to passage of activated cells from 
the blood into inflamed tissues (Jalkanen et al., 1986). How- 
ever,  the results  from Yednock et al.  (1992)  suggest that 
CD44 is not directly involved in the binding of lymphocytes 
to  inflamed vessels  of EAE rat brain.  Nevertheless,  our 
results suggest that CD44 is involved in the cellular interac- 
tions  controlling  lymphocyte retention  within  the  CNS, 
namely T cell binding to astrocytes. 
Our in vitro studies on the adhesion of T ceils to astrocytes 
show  that  these  two  cell  types  are  able  to  bind  in  an 
activation-dependent manner. PMA activation of either the 
Hll.1 T cell hybridoma or the astrocyte monolayer resulted 
in increased adhesive interaction, and binding was maximal 
when both cell types were activated (Fig. 9 a). The combined 
results of inhibition by hyaluronidase treatment (Fig. 9 b), 
soluble HA (Fig. 9 c) and mAb KM81 (Fig. 9, d and e) indi- 
cate that CIM4 molecules on both astrocytes and Hll.1 T 
cells  participate  in  cell-cell  adhesion,  and that the  HA- 
binding domain is crucial for this interaction. In correlation, 
recent work on HA binding through CD44 shows that IL-5 
activated B cells, expressing abundant CD44, can bind to 
HA-coated dishes (Murakami et al.,  1991). Lymphoid cell 
lines stimulated with PMA also show increased binding of 
fluorescein-labeled HA (Lesley et al.,  1990).  However,  not 
all CD44  + cell lines are able to bind HA (Hyman et al., 
1991). In all these experiments, it remains to be determined 
whether a particular variant form of CD44 is responsible for 
HA binding. 
As shown in Fig. 9 c, PMA-treated cells were more resis- 
tant to inhibition of binding by HA than unstimulated cells. 
This result suggests that other adhesion molecules or non- 
HA binding isoforms of CD44 may be involved in the bind- 
ing between astrocytes and T cells. Thus, leukocyte function 
accessory  molecule-1  (LFA-1) and  intercellular  adhesion 
molecule-1  (ICAM-1)  are  immunological adhesion  mole- 
cules implicated in cell contacts driving stimulation of astro- 
cytes in inflammation. ICAM-1 has been reported to be in- 
creased  on the  cell  surface  of astrocytes through "y-IFN 
stimulation (Hertz et al.,  1990),  and similarly, treatment 
of human astrocytes with ot-TNF can induce expression of 
E-selectin, VCAM-1, and ICAM-1 adhesion molecules (Hur- 
witz et al.,  1992).  These results might account, at least in 
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activated astrocytes. 
In  vivo,  a-TNF  production  and  activated  astrocytes 
proliferation  are observed in EAE lesions, while activated 
lymphocytes are  accumulating  in  these  sites.  Results  ob- 
tained in the present study show that regulation of the CD44 
adhesion molecule may play an important role in the patho- 
genesis of multiple sclerosis.  Expression of multiple  adhe- 
sion molecules by lymphocytes and astrocytes may regulate 
the  persistence  of  lymphocytes  at  sites  of inflammation 
within  the CNS. 
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Note Added in Proof'.  During the process of this manuscript, Cruz et al. 
(1993.  Cell Adhesion  and Communication.  1:9-20) reported that a glyco- 
protein expressed by human fibrous astrocytes and  which bound hyal- 
uronate was by biochemical criteria a membrane of the CD44 family. 
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